Faculty profile

Cynthia Gagnon

ResearcherEcole de réadaptationUniversité de Sherbrooke

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université de Sherbrooke directory, so their courses may be missing. Find their university profile.

Cynthia Gagnon

Researcher

Ecole de réadaptation

Health Sciences

Université de Sherbrooke

Sherbrooke, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
62 publications in the last five years, latest in 2026.
Senior (last) author on 17 recent papers, a sign of leading a research group.
Principal investigator on 4 research grants (4 CIHR), most recently in 2023.
Supervisor on 2 trainee awards (2 CIHR), most recently in 2026.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

119

Publications

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Natural History Study Mobility Physical Impairments Artificial Intelligence Master Observational Trial Neuromuscular Disorders Omics Platform Patient-Partner Approach

Latest papers

Muscle Strength, Balance, and Indoor Mobility in Oculopharyngeal Muscular Dystrophy: An Exploratory Canadian Multicenter Study.
Muscle & nerve · 2026 · senior author
Gynecological and Obstetrical Issues Experienced by Women Diagnosed with Myotonic Dystrophy Type 1: A Scoping Review.
Journal of women's health (2002) · 2026 · first author
Strengthening clinical capacity in spinal muscular atrophy: Developing and implementing training on clinical outcome assessments.
Journal of neuromuscular diseases · 2026

All 119 publications

Latest funding

Évaluation de la cognition sociale en dystrophie myotonique de type 1: L'apport de la réalité virtuelle
CIHR · 2026 · Supervisor
$9,000
Développement et validation d'un instrument de mesure évaluant la pratique infirmière en soins primaires
CIHR · 2024 · Supervisor
$120,000
Performing a Rare disease-Oriented Master Observational Trial to decipher complexity and optimize trial readiness
CIHR · 2023 · Nominated PI
$431,253

All 6 grants and awards

119 publications.

Muscle Strength, Balance, and Indoor Mobility in Oculopharyngeal Muscular Dystrophy: An Exploratory Canadian Multicenter Study.

Bélair N, Brisson JD, Brais B, Rodrigue X, Lochmüller H, Hébert LJ, MacGregor J, Dennison B, Lessard I, Côté I, Duchesne E, Gagnon C

Muscle & nerve2026Senior author

DOI: 10.1002/mus.70343 PMID: 42439050

Gynecological and Obstetrical Issues Experienced by Women Diagnosed with Myotonic Dystrophy Type 1: A Scoping Review.

Gagnon C, Savard C, Fisette-Paulhus I, Tamizi A, Tremblay A, Lavoie M, Morin M

Journal of women's health (2002)2026First author

DOI: 10.1177/15409996261454984 PMID: 42272165

Strengthening clinical capacity in spinal muscular atrophy: Developing and implementing training on clinical outcome assessments.

Osman H, Masnata M, Adamji Z, Rodrigue X, Nguyen CÉ, Slayter J, Beattie E, Lintern S, Lochmuller H, O'Connell C, Gagnon C, Warman-Chardon J

Journal of neuromuscular diseases2026

DOI: 10.1177/22143602261416298 PMID: 41564276

Large-scale proteomics profiling of peripheral blood of DM1 patients identifies biomarkers for disease severity and functional capacity.

van As D, Claeys T, Salz R, Haver DV, Dufour S, Deelen AV, Gloerich J, Gabriels R, Volders PJ, Dobelmann V, Gangfuss A, Ruck T, Gourdon G, Duchesne E, Gagnon C, Roos A, Gool AV, Impens F, Martens L, Lochmüller H, Schoser B, Bassez G, van Engelen BG, 't Hoen PA, OPTIMISTIC consortium, ReCognitION consortium

Journal of neuromuscular diseases2026

DOI: 10.1177/22143602251410443 PMID: 41544176

Longitudinal Psychometric Properties of the Myotonic Dystrophy Health Index in a Large Multicenter Cohort of People Living With Myotonic Dystrophy Type 1.

Sansone VA, Lizio A, Ferrari Aggradi CR, Greco LC, Gagnon C, Subramony S, Roxburgh RH, Mul K, Hamel J, Eichinger K, Hung M, Statland JM, Turner C, Elsheikh B, Schoser B, Ragole T, Matthews E, Sampson J, Takahashi MP, Wicklund M, Swenson A, Laverty CG, Shieh P, Greene EP, Beretta M, Casiraghi JL, Dekdebrun J, Raymond J, Langeslay R, DeSpain E, Thornton CA, Heatwole C, Johnson NE, Myotonic Dystrophy Clinical Research Network

Muscle & nerve2026

DOI: 10.1002/mus.70277 PMID: 42115131

What is known about muscle weakness, balance impairments and indoor mobility limitations in oculopharyngeal muscular dystrophy? A scoping review.

Bélair N, Gagnon C, Duchesne E

Journal of neuromuscular diseases2026

DOI: 10.1177/22143602251397052 PMID: 41467981

Short-term course of the neuropsychological profile in myotonic dystrophy type 1: a 12-month longitudinal study.

Fortin J, Gaudet I, Côté I, Gagnon C, Gallais B

BMC neurology2026

DOI: 10.1186/s12883-026-04816-6 PMID: 42050457

The Cerebellar Cognitive-Affective Syndrome Scale Reveals Consistent, Early, and Progressive Neuropsychological Deficits in Autosomal-Recessive Spastic Ataxia of Charlevoix-Saguenay: A Large International Cross-Sectional Study.

Fortin J, Synofzik M, Pedneault-Tremblay ÉA, Hermle D, Thieme A, Timmann D, La Piana R, Brais B, Dolbec J, Côté I, Gagnon C, Traschütz A

Movement disorders : official journal of the Movement Disorder Society2026

DOI: 10.1002/mds.70201 PMID: 41669957

Endogenous circadian rhythm sleep disorders through the lens of nonparametric variables of actigraphy: an exploratory study in myotonic dystrophy type 1.

Laberge L, Turcotte O, Angeard N, Maltais A, Martin JS, Gagnon C

Sleep medicine2026Senior author

DOI: 10.1016/j.sleep.2026.108781 PMID: 41547321

Establishing biomarkers and clinical endpoints in myotonic dystrophy type 1 (END-DM1): Protocol of an international natural history study.

Mul K, Eichinger K, Hung M, Sansone VA, Gagnon C, Subramony S, Roxburgh RH, Hamel J, Statland JM, Elsheikh B, Turner C, Sampson J, Ragole T, Matthews E, Schoser B, Swenson A, Laverty C, Shieh P, Greene EP, Takahashi M, Wicklund M, Dekdebrun J, Raymond J, DeSpain E, Thornton CA, Johnson NE, Myotonic Dystrophy Clinical Research Network

PloS one2025

DOI: 10.1371/journal.pone.0331163 PMID: 41379803

Something wrong or missing on this profile? Suggest a correction

Cynthia Gagnon

Research

Latest papers

Latest funding

Muscle Strength, Balance, and Indoor Mobility in Oculopharyngeal Muscular Dystrophy: An Exploratory Canadian Multicenter Study.

Gynecological and Obstetrical Issues Experienced by Women Diagnosed with Myotonic Dystrophy Type 1: A Scoping Review.

Strengthening clinical capacity in spinal muscular atrophy: Developing and implementing training on clinical outcome assessments.

Large-scale proteomics profiling of peripheral blood of DM1 patients identifies biomarkers for disease severity and functional capacity.

Longitudinal Psychometric Properties of the Myotonic Dystrophy Health Index in a Large Multicenter Cohort of People Living With Myotonic Dystrophy Type 1.

What is known about muscle weakness, balance impairments and indoor mobility limitations in oculopharyngeal muscular dystrophy? A scoping review.

Short-term course of the neuropsychological profile in myotonic dystrophy type 1: a 12-month longitudinal study.

The Cerebellar Cognitive-Affective Syndrome Scale Reveals Consistent, Early, and Progressive Neuropsychological Deficits in Autosomal-Recessive Spastic Ataxia of Charlevoix-Saguenay: A Large International Cross-Sectional Study.

Endogenous circadian rhythm sleep disorders through the lens of nonparametric variables of actigraphy: an exploratory study in myotonic dystrophy type 1.

Establishing biomarkers and clinical endpoints in myotonic dystrophy type 1 (END-DM1): Protocol of an international natural history study.

Évaluation de la cognition sociale en dystrophie myotonique de type 1: L'apport de la réalité virtuelle

Développement et validation d'un instrument de mesure évaluant la pratique infirmière en soins primaires

Performing a Rare disease-Oriented Master Observational Trial to decipher complexity and optimize trial readiness

A comprehensive study of the natural history of OPMD: An essential step towards clinical trial readiness and evidence-based interventions

A comprehensive study of the natural history of ARSACS: An essential step towards clinical trial readiness and evidence-based interventions

Motor, multisystemic and social participation assessment in myotonic dystrophy type 1: a 9-year longitudinal study.

Frequent collaborators

Cynthia Gagnon

Bernard Brais

Elise Duchesne

Bernard Brais

Elise Duchesne

Homira Osman

Jodi Warman Chardon

Hanns Lochmüller

Luigi Bouchard

Luigi Bouchard

Gerald Pfeffer

Kednapa Thavorn

Bernard Brais

Maud-Christine Chouinard

Kednapa Thavorn

Lawrence Korngut

Isabelle Laforest-Lapointe

Krista Best

Roberta La Piana

Reshma Amin

Susan Cadell

Cynthia Gagnon

Aymeric Ravel-Chapuis

Nicolas Dumont

Reggie Hamdy

Serge McGraw

Luc Noreau

Gregor Andelfinger

Martin Fortin

Noémi Dahan-Oliel

Maryam Oskoui